Mode
Text Size
Log in / Sign up

Single-cell RNA sequencing identifies post-capillary venules and ADAM12+ fibroblasts as potential keloid targetsNew research identifies specific cell types driving keloid scar growth

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note post-capillary venules and ADAM12+ fibroblasts as potential targets for keloid therapy pending functional validation.

This meta-analysis synthesizes single-cell RNA sequencing (scRNA-seq) data from 147 samples to identify transcriptional programs associated with keloid formation across Asian, Black, and White populations. The analysis identifies significant expansions in both vascular endothelial cells and fibroblasts within keloid tissue compared to healthy skin.

Key findings include a higher proportion of post-capillary venules and arteriolar states in keloids, as well as the expansion of mesenchymal/ADAM12+ and pro-inflammatory fibroblast populations. Furthermore, the study identifies ethnicity-specific differences: Asian and Black populations showed higher endothelial proportions, while White populations exhibited greater fibroblast expansion. Candidate pathogenic pathways include TGF-beta/SMAD, integrin/FAK, and YAP/TAZ mechanotransduction.

The authors note that cross-study differences may complicate the generalization of these results. Additionally, the identified pathogenic programs require functional validation to establish causality. These findings suggest that post-capillary venules and ADAM12+ fibroblasts may serve as specific targets for future therapeutic interventions in keloid management.

How this fits prior evidence

This meta-analysis extends the existing understanding of keloid pathology by identifying specific cellular subtypes, such as post-capillary venules and ADAM12+ fibroblasts, as potential therapeutic targets. It complements the previously reported mechano-immunology framework for keloid management strategies by providing a transcriptomic basis for these mechanisms. While previous evidence highlighted vitamin D as a safer alternative to steroids, this study focuses on identifying cellular pathways that may inform future individualized treatment strategies.

Keloids are thick, raised scars that can be difficult to manage. New research using advanced cell mapping has pinpointed exactly which cells are involved in this process. By looking at samples from Asian, Black, and White populations, scientists found that both blood vessel cells (endothelial cells) and skin cells (fibroblasts) grow in higher amounts in keloid tissue compared to healthy skin.

The study revealed that these cell types behave differently depending on a person's background. For example, some blood vessel types were more prominent in Asian and Black patients, while certain skin cell groups were more common in White patients. These specific cells are linked to inflammation and the way the body heals tissue.

While these findings help identify potential targets for future treatments, it is important to note that this research was based on computer modeling of genetic data. The study shows a link between these cells and keloid growth, but more testing is needed to prove they cause the condition directly.

What this means for you:
Specific types of blood vessel and skin cells are linked to keloid growth across different ethnicities.

Common questions

What did the study find about keloids?

The research found that keloid tissue contains higher proportions of fibroblasts (skin cells) and vascular endothelial cells (blood vessel cells) than healthy skin. Specifically, it identified an increase in post-capillary venules and arteriolar states, as well as a growth in pro-inflammatory skin cell populations.

Do keloid cells differ by ethnicity?

Yes, the study found differences based on population. Blood vessel cells were more prominent in Asian and Black populations compared to White populations. In contrast, certain types of skin cells (mesenchymal/ADAM12+) showed greater expansion in White patients.

Can these findings be used for treatment right away?

The study identifies specific cell types and pathways as potential targets for future treatments. However, because the results are based on computational inference of genetic data, these programs still require functional validation before they can be used in clinical practice.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Keloid is a fibroproliferative scar with marked ethnic disparities, disproportionately affecting Asian and Black populations. Single-cell RNA sequencing (scRNA-seq) studies have mapped keloid pathology, but cross-study differences complicate generalization. We performed a meta-analysis to identify composition and transcriptional programs associated with keloid across ethnicities. We aggregated human skin scRNA-seq datasets containing keloid and healthy samples with documented ethnicity (Asian, Black, White). After quality control and batch integration (scVI/scANVI), we annotated cell types and subtypes. Differential abundance was estimated with scCODA, Milo, and propeller. Pseudobulk differential expression was meta-analyzed using random-effects models. Ligand-receptor signaling was inferred with CellChat/NicheNet. The harmonized atlas comprised 112 donors, 147 samples, and 487,293 cells from 8 studies. Keloid demonstrated higher proportions of vascular endothelial cells and fibroblasts across all methods. Ethnicity-stratified analysis revealed endothelial expansion in Asian and Black relative to White populations, while fibroblast expansion was greater in White keloids. Endothelial subtyping showed increased post-capillary venules and arteriolar states. Fibroblast analysis revealed expansion of mesenchymal/ADAM12+ and pro-inflammatory populations. Meta-analysis implicated TGF-β/SMAD, integrin/FAK, and YAP/TAZ mechanotransduction pathways as candidate pathogenic programs warranting functional validation. Cross-study synthesis identifies shared and ethnicity-stratified endothelial and fibroblast programs in keloid. Expansion of post-capillary venules and ADAM12+ fibroblasts provides candidate therapeutic targets pending functional validation and a framework for understanding ethnic disparities in keloid formation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.